{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:09:06Z","timestamp":1790024946587,"version":"4.0.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,1]]},"abstract":"<jats:sec>\n            <jats:title>OBJECTIVE:<\/jats:title>\n            <jats:p>To summarize the effectiveness and safety outcomes of medication abortion performed without prior pelvic examination or ultrasonogram (\u201cno-test medication abortion\u201d).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>DATA SOURCES:<\/jats:title>\n            <jats:p>We searched the MEDLINE, Scopus, Web of Science, Cochrane (including ClinicalTrials.gov), CINAHL, Global Index Medicus, and CAB Direct databases to identify relevant studies published before April 2022 using a peer-reviewed search strategy including terms such as \u201cmedication abortion\u201d and \u201cultrasonography.\u201d We contacted experts in the field for unpublished data and ongoing studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>METHODS OF STUDY SELECTION:<\/jats:title>\n            <jats:p>We reviewed 2,423 studies using Colandr. We included studies if they presented clinical outcomes of medication abortion performed with mifepristone and misoprostol and without prior pelvic examination or ultrasonogram. We excluded studies with duplicate data. We abstracted successful abortion rates overall, as well as rates by gestational age through 63 days, 70 days and past 84 days. We abstracted complication rates, including the need for surgical evacuation, additional medications, blood transfusion, and ectopic pregnancy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>TABULATION, INTEGRATION AND RESULTS:<\/jats:title>\n            <jats:p>We included 21 studies with a total of 10,693 patients with outcome data reported. The overall efficacy of no-test medication abortion was 96.4%; 93.8% (95% CI 92.8\u201394.6%) through 63 days of gestation and 95.2% (95% CI 94.7\u201395.7%) through 70 days of gestation. The overall rate of surgical evacuation was 4.4% (95% CI 4.0\u20134.9), need for additional misoprostol 2.2% (95% CI 1.8\u20132.6), blood transfusion 0.5% (95% CI 0.3\u20130.6), and ectopic pregnancy 0.06% (95% CI 0.02\u20130.15).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>CONCLUSION:<\/jats:title>\n            <jats:p>Medication abortion performed without prior pelvic examination or ultrasonogram is a safe and effective option for pregnancy termination.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>SYSTEMATIC REVIEW REGISTRATION:<\/jats:title>\n            <jats:p>PROSPERO, CRD42021240739.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/aog.0000000000005016","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T22:01:49Z","timestamp":1671141709000},"page":"23-34","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":35,"title":["No-Test Medication Abortion"],"prefix":"10.1097","volume":"141","author":[{"given":"Marit","family":"Pearlman Shapiro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Dethier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Kahili-Heede","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bliss","family":"Kaneshiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,12,5]]},"reference":[{"key":"R1-20250423","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.ss6907a1","article-title":"Abortion surveillance\u2014United States, 2018","volume":"69","author":"Kortsmit","year":"2020","journal-title":"MMWR Surveill Summ"},{"key":"R2-20250423","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1097\/AOG.0000000000004082","article-title":"Medication abortion up to 70 days of gestation. ACOG Practice Bulletin No. 225. American College of Obstetricians and Gynecologists","volume":"136","year":"2020","journal-title":"Obstet Gynecol"},{"key":"R5-20250423","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.contraception.2010.06.014","article-title":"Comprehensive analysis of the use of pre-procedure ultrasound for first- and second-trimester abortion","volume":"83","author":"Kulier","year":"2011","journal-title":"Contraception"},{"key":"R6-20250423","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.contraception.2014.07.004","article-title":"The accuracy of using last menstrual period to determine gestational age for first trimester medication abortion: a systematic review","volume":"90","author":"Schonberg","year":"2014","journal-title":"Contraception"},{"key":"R7-20250423","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.contraception.2015.04.008","article-title":"Early medical abortion without prior ultrasound","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"R8-20250423","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1471-0528.2010.02753.x","article-title":"Alternatives to routine ultrasound for eligibility assessment prior to early termination of pregnancy with mifepristone-misoprostol","volume":"118","author":"Bracken","year":"2011","journal-title":"BJOG"},{"key":"R9-20250423","doi-asserted-by":"crossref","first-page":"710.e1","DOI":"10.1016\/j.ajog.2021.11.1373","article-title":"Accuracy of self-assessment of gestational duration among people seeking abortion","volume":"226","author":"Ralph","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20250423","doi-asserted-by":"crossref","first-page":"278","DOI":"10.3109\/00016349209021052","article-title":"Medical termination of early pregnancy with mifepristone (RU 486) followed by a prostaglandin analogue. Study in 16, 369 women","volume":"71","author":"Ulmann","year":"1992","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R11-20250423","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10995-019-02842-0","article-title":"Trends in ectopic pregnancy diagnoses in United States emergency departments, 2006-2013","volume":"24","author":"Mann","year":"2020","journal-title":"Matern Child Health J"},{"key":"R12-20250423","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.contraception.2015.06.020","article-title":"Reaching women where they are: eliminating the initial in-person medical abortion visit","volume":"92","author":"Raymond","year":"2015","journal-title":"Contraception"},{"key":"R13-20250423","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.contraception.2016.04.013","article-title":"Medical abortion reporting of efficacy: the MARE guidelines","volume":"94","author":"Creinin","year":"2016","journal-title":"Contraception"},{"key":"R14-20250423","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0090-6980(77)90207-6","article-title":"15(S)15-methyl prostaglandin F2alpha for termination of very early human pregnancy. A comparative study of a single intramuscular injection and vaginal suppositories","volume":"14","author":"Fylling","year":"1977","journal-title":"Prostaglandins"},{"key":"R15-20250423","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1447-0756.1982.tb00574.x","article-title":"Termination of early first trimester pregnancy by vaginal administration of 16, 16-dimethyl-trans-delta 2-PGE1 methyl ester","volume":"8","author":"Purandare","year":"1982","journal-title":"Asia Oceania J Obstet Gynaecol"},{"key":"R16-20250423","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/0090-6980(82)90035-1","article-title":"\u201cMenstrual induction\u201d with sulproston","volume":"24","author":"Csapo","year":"1982","journal-title":"Prostaglandins"},{"key":"R17-20250423","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.contraception.2021.03.025","article-title":"Provision of medication abortion in Hawai'i during COVID-19: practical experience with multiple care delivery models","volume":"104","author":"Kerestes","year":"2021","journal-title":"Contraception"},{"key":"R18-20250423","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.contraception.2021.07.108","article-title":"Clinical and service delivery implications of omitting ultrasound before medication abortion provided via direct-to-patient telemedicine and mail in the U.S.","volume":"104","author":"Anger","year":"2021","journal-title":"Contraception"},{"key":"R19-20250423","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/jamainternmed.2022.0217","article-title":"Outcomes and safety of history-based screening for medication abortion: a retrospective multicenter cohort study","volume":"182","author":"Upadhyay","year":"2022","journal-title":"JAMA Intern Med"},{"key":"R20-20250423","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/1471-0528.16668","article-title":"Effectiveness, safety and acceptability of no-test medical abortion (termination of pregnancy) provided via telemedicine: a national cohort study","volume":"128","author":"Aiken","year":"2021","journal-title":"BJOG"},{"key":"R21-20250423","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/AOG.0b013e31823fe923","article-title":"The comparative safety of legal induced abortion and childbirth in the United States","volume":"119","author":"Raymond","year":"2012","journal-title":"Obstet Gynecol"},{"key":"R22-20250423","first-page":"122","article-title":"Unsafe abortion: unnecessary maternal mortality","volume":"2","author":"Haddad","year":"2009","journal-title":"Rev Obstet Gynecol"},{"key":"R23-20250423","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/1471-0528.15684","article-title":"Telemedicine for medical abortion: a systematic review","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG"},{"key":"R24-20250423","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/1471-0528.15922","article-title":"Effectiveness, safety and acceptability of self-assessment of the outcome of first-trimester medical abortion: a systematic review and meta-analysis","volume":"126","author":"Baiju","year":"2019","journal-title":"BJOG"},{"key":"R25-20250423","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/1471-0528.15553","article-title":"Safety and acceptability of medical abortion through telemedicine after 9 weeks of gestation: a population-based cohort study","volume":"126","author":"Endler","year":"2019","journal-title":"BJOG"},{"key":"R26-20250423","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijgo.2013.07.038","article-title":"Use of telemedicine for providing medical abortion","volume":"124","author":"Wiebe","year":"2014","journal-title":"Int J Gynaecol Obstet"},{"key":"R27-20250423","doi-asserted-by":"crossref","first-page":"j2011","DOI":"10.1136\/bmj.j2011","article-title":"Self reported outcomes and adverse events after medical abortion through online telemedicine: population based study in the Republic of Ireland and Northern Ireland","volume":"357","author":"Aiken","year":"2017","journal-title":"BMJ"},{"key":"R28-20250423","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.contraception.2017.11.005","article-title":"Simplified medical abortion screening: a demonstration project","volume":"97","author":"Raymond","year":"2018","journal-title":"Contraception"},{"issue":"suppl 1","key":"R29-20250423","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1363\/46e1020","article-title":"Feasibility of multilevel pregnancy tests for telemedicine abortion service follow-up: a pilot study","volume":"46","author":"Chong","year":"2020","journal-title":"Int Perspect Sex Reprod Health"},{"key":"R30-20250423","doi-asserted-by":"crossref","first-page":"100023","DOI":"10.1016\/j.conx.2020.100023","article-title":"Comparing telemedicine to in-clinic medication abortions induced with mifepristone and misoprostol","volume":"2","author":"Wiebe","year":"2020","journal-title":"Contracept X"},{"key":"R31-20250423","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.contraception.2021.04.026","article-title":"Family medicine provision of online medication abortion in three US states during COVID-19","volume":"104","author":"Godfrey","year":"2021","journal-title":"Contraception"},{"key":"R32-20250423","doi-asserted-by":"crossref","first-page":"100057","DOI":"10.1016\/j.conx.2021.100057","article-title":"Medical abortion at 13 or more weeks gestation provided through telemedicine: a retrospective review of services","volume":"3","author":"Kapp","year":"2021","journal-title":"Contracept X"},{"key":"R33-20250423","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1136\/bmjsrh-2020-200976","article-title":"Telemedicine medical abortion at home under 12 weeks' gestation: a prospective observational cohort study during the COVID-19 pandemic","volume":"47","author":"Reynolds-Wright","year":"2021","journal-title":"BMJ Sex Reprod Health"},{"key":"R34-20250423","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/aogs.14040","article-title":"Does prior ultrasonography affect the safety of induced abortion at or after 13 weeks' gestation? A retrospective study","volume":"100","author":"Kapp","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"R35-20250423","doi-asserted-by":"crossref","DOI":"10.2139\/ssrn.3861578","article-title":"A prospective, comparative study of clinical outcomes following clinic-based versus self-use of medical abortion","author":"Kapp","year":"2021","journal-title":"SSRN Electronic J"},{"key":"R36-20250423","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/S2214-109X(21)00461-7","article-title":"Effectiveness of self-managed medication abortion with accompaniment support in Argentina and Nigeria (SAFE): a prospective, observational cohort study and non-inferiority analysis with historical controls","volume":"10","author":"Moseson","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R37-20250423","first-page":"100200","article-title":"Safety and effectiveness of self-managed medication abortion provided using online telemedicine in the United States: a population based study","volume":"10","author":"Aiken","year":"2022","journal-title":"Lancet Reg Health Am"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T18:01:42Z","timestamp":1745431302000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000005016"}},"subtitle":["A Systematic Review"],"short-title":[],"issued":{"date-parts":[[2022,12,5]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000005016","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12,5]]},"assertion":[{"value":"2022-07-13","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-22","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}